Trial Profile
Study of central abdominal uptake on indium-111 capromab pendetide imaging: a powerful prognostic indicator for prostate cancer in high-risk patients and in the setting of biochemical recurrence
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2018
Price :
$35
*
At a glance
- Drugs Capromab (Primary)
- Indications Prostate cancer
- Focus Diagnostic use; Therapeutic Use
- 21 May 2018 Results (n=50) assessing the relationship between CAU and prostate cancer treatment failure presented at the 113th Annual Meeting of the American Urological Association
- 21 May 2018 New trial record